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1Department of Chemistry and Biochemistry, University of Maryland Baltimore County, Baltimore, MarylandABSTRACT The RNA-dependent RNA polymerase from the Hepatitis C Virus (gene product NS5B) is a validated drug target
because of its critical role in genome replication. There are at least four distinct allosteric sites on the polymerase to which
several small molecule inhibitors bind. In addition, numerous crystal structures have been solved with different allosteric inhib-
itors bound to the polymerase. However, the molecular mechanisms by which these small molecules inhibit the enzyme have
not been fully elucidated. There is evidence that allosteric inhibitors alter the intrinsic motions and distribution of conformations
sampled by the enzyme. In this study we use molecular dynamics simulations to understand the structural and dynamic
changes that result when inhibitors are bound at three different allosteric binding sites on the enzyme. We observe that ligand
binding at each site alters the structure and dynamics of NS5B in a distinct manner. Nonetheless, our studies also highlight
commonalities in the mechanisms of action of the different inhibitors. Each inhibitor alters the conformational states sampled
by the enzyme, either by rigidifying the enzyme and preventing transitions between functional conformational states or by de-
stabilizing the enzyme and preventing functionally relevant conformations from being adequately sampled. By illuminating the
molecular mechanisms of allosteric inhibition, these studies delineate the intrinsic functional properties of the enzyme and pave
the way for designing novel and more effective polymerase inhibitors. This information may also be important to understand
how allosteric regulation occurs in related viral polymerases and other enzymes.INTRODUCTIONThe Hepatitis C virus (HCV) infects ~3% of the world’s
population, making it a global health problem (1–3).
HCV possesses a positive stranded RNA genome that
can be immediately translated once it infects a host
cell. The resulting polyprotein is cleaved to give rise to
four structural proteins (core, E1, E2, and p7) and six
nonstructural proteins NS2, NS3, NS4A, NS4B, NS5A,
and NS5B) (1,3). NS5B is the RNA-dependent RNA
polymerase (see Fig. 1) that replicates the HCV genome
and is a validated drug target (3–5).
To function, NS5B is believed to interchange between at
least two conformations: a closed conformation required
for de novo initiation, and an open conformation required
for elongation of the newly transcribed RNA strand (6–8).
In the closed conformation, the thumb and fingers domains
are rotated closer toward each other such that residues within
the template channel are primed for initiation, while in the
open conformation the thumb and fingers domains are posi-
tioned further apart such that theRNAduplex channelwidens
to accommodate nascent double-stranded transcripts (7,8).
Previously (9), we usedmolecular simulations to identify a
fully closed NS5B conformation that we proposed to be suit-
able for de novo initiation, based on its resemblance to initi-
ation complexes of polymerases from related viruses such asSubmitted December 1, 2014, and accepted for publication March 4, 2015.
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0006-3495/15/04/1785/11 $2.00bacteriophage f6 or poliovirus (10). This conformation is
stabilized by the presence of two magnesium ions in the
palm domain and absence of the 60 C-terminal residues,
which allows for increased interaction between the fingers
and thumb domain via new hydrogen bonds (9). It is believed
that the C-terminus is necessary for docking the polymerase
to the endoplasmic reticulum membrane in vivo, as it is
extremely hydrophobic. In the absence of the endoplasmic
reticulummembrane, the C-terminus can become lodged be-
tween the fingers and thumb domains, which has been shown
to significantly decrease polymerase function in vitro (11).
Our previous computational studies demonstrated that
the C-terminus disrupts interactions between the thumb
and fingers domains, significantly decreasing flexibility and
limiting conformational sampling of NS5B (9).
A considerable effort has been made to identify inhibi-
tors that target the HCV polymerase. Two broad classes
of inhibitors that have been widely investigated as potential
therapeutics: active site and allosteric inhibitors (1,12). The
active site inhibitors are based on either nucleoside or py-
rophosphate scaffolds and function as chain terminators of
the nascent RNA transcript (13). Nucleoside inhibitors act
via preventing additional nucleotides from being incorpo-
rated, while pyrophosphate analogs coordinate the divalent
ions required for catalysis (e.g., magnesium or manganese
ions). This coordination prevents the departure of the
pyrophosphate group and obstructs binding of additional
nucleotides (13,14). In contrast to the active site inhibitors,http://dx.doi.org/10.1016/j.bpj.2015.03.005
TABLE 1 Description of simulated systems and associated
abbreviations
System
abbreviation
Enzyme
structure Description
Conventional
MD/TAMD/total
1 PDB: 2BRL 460/340/800
1:POO PDB: 2BRL L: POO (NNI-1) 0/500/500
2 PDB: 2WHO 400/0/400a
2:PFI PDB: 2WHO L:PFI (NNI-2) 0/500/500
2:VGI PDB: 2WHO L: VGI (NNI-2) 400/0/400a
3 PDB: 2HAI mutations: L47Q, F101Y,
K114R
500/200/700
3:PFI PDB: 2HAI mutations: L47Q, F101Y,
K114R L: PFI (NNI-2)
60/440/500
FIGURE 1 The RNA polymerase (NS5B) from
the hepatitis C virus showing locations of allosteric
sites and inhibitor structures. (Blue) Fingers, (red)
palm, and (green) thumb domains. The active site
is marked by an asterisk (*). Of the four allosteric
binding sites, three were examined in this study:
NNI-1, NNI-2, and NNI-3. Structures for each
ligand are shown in addition to their respective
IC50 values. To see this figure in color, go online.
1786 Davis et al.allosteric inhibitors (commonly referred to as nonnucleo-
side inhibitors or NNIs) bind distal to the polymerase
active site.
Of the four confirmed allosteric binding sites, two are
located in the thumb domain (NNI-1 and NNI-2) and two in
the palm domain (NNI-3 and NNI-4) (Fig. 1) (15–24). We
will refer to NNI-1 and -2 as ‘‘thumb inhibitors’’ while
NNI-3 and -4 will be referred to as ‘‘palm inhibitors’’. NNIs
encompass diverse chemical scaffolds and exhibit mecha-
nisms of action that have not been conclusively elucidated.
However, some studies suggest that palm NNIs like benzodi-
azepine derivatives inhibit initiation while thumb NNIs such
as benzimidazole derivatives inhibit an early phase of replica-
tion that occurs after initiation, but precedes elongation
(23,25–27). Previously, we used molecular dynamics (MD)
simulations to demonstrate that an NNI-2 inhibitor forces
the enzyme to adopt a hyperclosed conformation (28). The
hyperclosed conformation is distinct from the fully closed
conformation that we previously characterized for an inhibi-
tor-free enzyme (9), as it has a template channel that is likely
to be too narrow to accommodate an RNA strand. While the
fully closed conformationmay be ideal for de novo initiation,
it is likely that the hyperclosed conformation represents a
nonfunctional conformational state (28).
In this work, MD simulations were employed to resolve
the molecular mechanisms of inhibition for palm and thumb
inhibitors (Fig. 1). We provide evidence that the structure
and dynamics of ligand-bound enzymes are significantly
different from those of the free enzymes and that these dif-
ferences may play a role in mediating the inhibitory effects
of these molecules. While our observations indicate that
palm and thumb inhibitors induce distinct structural and dy-
namic effects, both classes of inhibitors have the common
feature of disrupting the equilibrium distribution of confor-
mations sampled by the enzyme in ways that would tend to
reduce its activity.4 PDB: 3CO9 510/200/710
4:3MS PDB: 3CO9 L: 3MS (NNI-3) 500/200/700
5 PDB: 3HHK 500/400/900
5:77Z PDB: 3HHK L: 77Z (NNI-3) 0/500/500
All systems contain 531 amino acids and magnesium ions. L ¼ ligand-
bound (NNI-site). Totals are underlined.
aValues obtained from a previous study (28).MATERIALS AND METHODS
Simulation conditions
Crystal structures of the genotype 1b HCV RNA polymerase (NS5B)
from the Protein Data Bank (PDB) with the following PDB codes wereBiophysical Journal 108(7) 1785–1795used as the initial coordinates (location of the allosteric binding site is
in parentheses): PDB: 2BRL (NNI-1), PDB: 2HAI (NNI-2), PDB:
2WHO (NNI-2), PDB: 3CO9 (NNI-3), and PDB: 3HHK (NNI-3)
(19,21–24). The PDB: 2BRL crystal structure did not contain residues
22–35 (the D1 loop near the ligand binding site) or 148–152 (part of
the D2 loop). Coordinates for these residues were taken from PDB:
2WHO, placed into the PDB: 2BRL structure and energy-minimized.
Visual inspection confirmed that these residues were successfully incor-
porated. An RMSF profile of the residues in the D1 loop is provided
in Fig. S1 in the Supporting Material to demonstrate that there are
no abnormal motions that occur in this region when compared to the
other structures. Simulations with PDB: 2WHO were carried out in a pre-
vious study (28); however, some of the results are presented again here
for comparison. Each structure was simulated in a free and a ligand-
bound state. Ligands were parameterized using the protocol outlined in
Vanommesleaghe et al. (29), and ligand parameter files are available
upon request.
Descriptions and abbreviations applied to each simulated system are
listed in Table 1. Previously, we demonstrated that the presence of the
magnesium ions and deletion of the 60 C-terminal residues facilitates
conformational sampling (9). These conditions have been applied to
each of the systems described in this study. Each structure was placed
in a truncated octahedral unit cell that was larger than the protein by at
least 10 A˚ in each dimension, generating unit cells with an edge length
of at least 93 A˚. TIP3P (30) water molecules and 19 chloride ions were
added to the unit cell to solvate and neutralize the system, respectively.
All water molecules that overlapped with protein, ligand, or ions were
Allosteric Inhibitors of HCV Polymerase 1787deleted, resulting in simulation systems that contained ~60,000 atoms
each.
Simulations were performed using the CHARMM27 protein force field
and the CHARMM general force field (CGenFF, Ver. 2b6) (29–32) using
the software NAMD, Ver. 2.9 (33). Minimization of the solvated system
was carried out using NAMD for 1000 steps using the conjugate gradient
method and applying periodic boundary conditions. All bonds to hydrogen
atoms were constrained using the SHAKE algorithm, and electrostatic in-
teractions were calculated by the particle-mesh Ewald method. A distance
of 9 A˚ was used for the Coulomb cutoff and 11.4 A˚ for the nonbonded pair
list. Minimization was followed by 2,500,000 steps of simulation in the
NVTensemble at 300 K using NAMD and a 2-fs integration time step. Tem-
perature was maintained via velocity reassignment every 100 steps, during
which the positions of a-carbons was restrained using force constants of
10 kcal(mol1 A˚2).
The restrained NVT was followed by simulations in the NPT ensemble
at 300 K for 2,500,000 steps using Berendsen pressure coupling at
1.01 bar with a relaxation time of 100 fs. The temperature was maintained
via velocity reassignment every 100 steps. Finally, production NVT simula-
tions were performed using the same conditions as the original NVT simula-
tions, except that temperature was maintained using a Langevin thermostat
with a damping coefficient of 1 ps1 applied to heavy atoms. The pressure
was checked every 10 ns to confirm that it remained within reasonable range
of 1.01 bar.
Table 1 provides a description of each system and lists how much con-
ventional MD or temperature-acceleratedMD (TAMD) data were generated
for each structure. For simulations with TAMD data available, the final
200 ns of TAMD data were used for analysis (see TAMD discussion in
next section). Otherwise, the final 200 ns of conventional MD were
analyzed.TAMD
TAMD (34) was performed to complement the conventional MD simula-
tions in order to increase the sampling of open and closed conformations.
TAMD requires the selection of a collective variable (CV). A CV is a
combination of atomic coordinates that can act as a reaction coordinate
to be restrained or, in our case, driven using TAMD. We chose the
interdomain angle q (see Results and Discussion) as the single CV. A fric-
tion coefficient of 10 ps1 was used for the CV and its temperature was
set to 32 kBT. TAMD was implemented via a Tcl language interface
to NAMD provided by Dr. Cameron Abrams (Abrams and Vanden-Eijn-
den (35)).
While intended to enhance sampling, we observed that the sampling and
dynamics of q were not significantly altered in the TAMD simulations. We
believe this is due to the fact that, while q is a good progress variable for the
conformational changes sampled by NS5B, it is not a good reaction coordi-
nate. However, employing TAMD was still useful in providing additional
sampling that allowed for a more comprehensive representation of the
enzyme free energy landscape. Our observations indicate that the descrip-
tion of the free energy landscape provided by TAMD is essentially the
same as that obtained from conventional MD. Thus, results from TAMD
and conventional MD are presented on equivalent footing in these studies.
A complete discussion of the TAMD simulations is provided in Text S2 in
the Supporting Material.Measures of conformational sampling
To quantify the degree of closure, we employed two structural metrics, as
follows.
Interdomain angle (q)
The interdomain angle occurs at the intersection of the fingers, palm, and
thumb domains. It was computed by determining the angle between thecenters of mass of each domain. The residue composition of each
domain is defined according to Lesburg et al. (36): the fingers domain
contains residues 1–188 and 227–287, the palm domain contains resi-
dues 189–226, and 288–370, and the thumb domain contains residues
371–531.
Template channel width
The template channel width is calculated by measuring the distance be-
tween the centers of mass of residues 139 and 405. Smaller angles and nar-
rower widths correspond to a more closed enzyme. Values of 70 for q and
20 A˚ for the template channel width represent the demarcation between
open and closed conformations.
These values were chosen because they seem to give a natural separa-
tion between the distinct conformational minima displayed for the
different simulations, as shown in Fig. 2. Conformations for which both
criteria are not satisfied are classified as intermediate. Thus, the total pop-
ulation in the open and closed states does not necessarily equal to 100%
(see Results and Discussion below). It should be noted that our definition
of open and closed conformations differs from that employed by Gong and
Peersen (37). These authors defined the closed state as a conformation
where key active-site residues are aligned to adopt catalytically competent
conformations, while in the open state the active-site residues are not
aligned for catalysis. Thus, the definition employed by these authors de-
scribes the local vicinity of the active site while the definition employed
in this work describes the overall enzyme structure. We note that the defi-
nition employed here is consistent with that employed by other authors
who discuss these conformational states in the context of the global
enzyme structure (8,38–40).Root-mean-square fluctuations
The root-mean-square fluctuation (RMSF) was calculated to determine the
localized flexibility of the enzyme using Eq. 1. RMSF is calculated by sub-
tracting the average position ~xi of each atom from its instantaneous position
xi(tj), as
RMSFi ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPT
tj

xi

tj
 ~xi
2
T=dt
vuut
(1)
DRMSFi ¼ xF;i  xL;i; (2)
where T is the total length of the trajectory, tj is a time point, and dt is the
time interval at which coordinates were written out. RMSF values for theligand-bound structures were subtracted from those of the corresponding
free structures to generate DRMSF values, as shown in Eq. 2. DRMSF
values >0 indicate that free (xF,i) structures are more flexible while those
<0 indicate that ligand-bound (xL,i) structures are more flexible.Hydrogen-bond analysis
Hydrogen bonds were detected with the CORMAN module in the software
CHARMM (http://www.charmm.org/) using the default settings, which
specify a cutoff distance of 2.40 A˚ between hydrogen and acceptor and
no angle cutoff. A hydrogen bond was considered to be present if it dis-
played occupancy >0.2, where occupancy is defined as the number of
frames in which the bond occurs divided by the total number of frames
in a trajectory.Covariance calculations
Covariance analysis was performed to identify correlations between protein
motions throughout the simulation. The correlation (Ci,j) between twoBiophysical Journal 108(7) 1785–1795
FIGURE 2 Plots of interdomain angle (q) and template channel width
demonstrate changes in enzyme conformation upon ligand binding. (A)
The value q is calculated by measuring the angle between the centers of
mass of each domain. (B) The template channel width is calculated by
measuring the distance between the centers of mass of residues 139 and
405 (indicated by yellow spheres). (C) q (x axis) versus template channel
width (y axis) for each system. Smaller angles and narrower widths corre-
spond to a more closed enzyme. Values of 70 for q and 20 A˚ for the tem-
plate channel width (green lines in the plots) represent the demarcation
between open and closed conformations. (Black circles) Snapshots from
the free enzyme simulations; (red or blue circles) ligand-bound snapshots;
(green X on each plot) original x-ray crystal structures. To see this figure in
color, go online.
1788 Davis et al.atoms i and j is determined by calculating the dot product between the dif-
ferences of each atom’s current position (ri) from its average position (hrii)
using the CORREL module of the software CHARMM (http://www.
charmm.org/):
Ci;j ¼
ðri  hriiÞ ,

rj 

rj

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
hðri  hriiÞi2

rj 

rj
2q : (3)
The most significant changes in correlated motion upon ligand binding are
observed for 1/1:POO (see Fig. S3) and 2/2:VGI (28). In the former, pres-
ence of POO increases the extent of correlated motions, while the presence
of VGI decreases correlated motions.Biophysical Journal 108(7) 1785–1795NETWORKVIEW plug-in: critical residues
The NETWORKVIEW plug-in for VMD (41) was used to identify residues
likely to be critical for allosteric communication in NS5B. To begin, trajec-
tories containing the centers of mass of each residue and the ligand (if pre-
sent in that system) were generated. These were analyzed to generate an
allosteric communication network. Networks are sets of nodes in which
pairs of nodes are connected by edges. In this analysis, each center of
mass is considered a node. Two nodes are connected by an edge if the nodes
are within 8.5 A˚ of each other for at least 75% of the trajectory. Residues
adjacent in sequence are excluded and cannot be connected by an edge.
Edges are weighted according to the correlation between residues as
computed via Eq. 3. Path-lengths between distant nodes are calculated by
summing the edge weights between consecutive nodes along a path and
the shortest path distance between all pairs of nodes in the network is eval-
uated using the Floyd-Warshall algorithm. The betweenness of an edge is
measured by calculating the number of shortest paths that cross that
edge. The Girvan-Newman algorithm (42) was used to calculate commu-
nities in the network, which are collections of nodes that have more connec-
tions to other nodes in the community than to any other node outside the
community. Allosteric communication is thought to occur preferentially
over edges between two communities with the greatest betweenness. Pairs
of residues connected by such edges are considered critical residues.RESULTS AND DISCUSSION
We performed a total of nine simulations: four with free
enzyme and five with a ligand bound (three thumb-bound
and two palm-bound structures). In addition, results from
a previous set of simulations including an NNI-2 inhibitor
are included here for completeness (28). We confirmed
that the ligands remained bound to the enzyme throughout
the simulations via visual inspection of each trajectory.
Fig. 1 shows the structures of each ligand and their corre-
sponding IC50 values (19,21–24).
Overall, ligand binding shifts the conformational sam-
pling of the enzyme compared to the free structures, which
is demonstrated by the distributions of interdomain angles
(q) and template channel widths shown in Fig. 2. Panels A
and B in Fig. 2 illustrate how q and the template channel
width are calculated. Panel C shows the conformation
sampled by various free structures (indicated by a single
number, e.g., 1), ligand-bound structures (a number fol-
lowed by a colon and the ligand identifier, e.g., 1:POO),
and the respective original crystal structure given by the
PDB codes (all PDB codes used are listed in Table 1).
The changes in conformation upon ligand binding are
accompanied by changes in enzyme flexibility, hydrogen
bonding, and correlated motions, demonstrating that the
structural and dynamic effects of ligand binding propagate
throughout the entire enzyme and impact diverse enzyme
properties.Thumb site I (NNI-1) inhibitors reduce enzyme
stability
The NNI-1 binding site is at the intersection of the D1
loop (residues 25–35) and rear of the thumb domain on
Allosteric Inhibitors of HCV Polymerase 1789NS5B (see Figs. 1 and 3). Inhibitors binding to this site were
originally referred to as ‘‘finger-loop’’ inhibitors (43) and
are thought to prevent initiation of RNA replication
(19). NNI-1 ligands disrupt a number of hydrogen bonds
between the fingers and thumb domains and interact with
the protein via hydrophobic interactions (19). Several re-
searchers suggest that ligand binding at this site disrupts
vital communication between the D1 loop and thumb
domain, locking the enzyme into an open conformation
(19). These suggestions are due in part to the similarity of
NNI-1 bound structures to that of NS5B from genotype 2a
(PDB: 1YV2), which is thought to be in the open conforma-
tion (19,39). While our simulations do indicate that the
NNI-1 inhibitor disrupts communication between the D1
loop and thumb domain, we do not observe that the enzyme
becomes trapped in an open conformation. Instead, our
results indicate that the NNI-1-bound enzyme is unable to
stably adopt either open or closed conformations, because
it rapidly samples conformations with average q-valuesFIGURE 3 NNI-1 binding site displaying key hydrogen bonds between
the fingers and thumb domains. (Upper panel) The free structure; (lower
panel) ligand-bound structure. The hydrogen bond between residue H33
and L492 (occupancy of 80%) in 1 is disrupted upon ligand binding.
Hydrogen bonds between residues S29 and R503 and between R32 and
G493 also occur in most of the other structures, with occupancies ranging
from 20 to 80%. To see this figure in color, go online.and template channel widths of 74 and 25 A˚, and 69 and
20 A˚, respectively.
Fig. 2 compares conformations sampled in the free and
ligand-bound structures. Simulation 1 samples an open con-
formation for 91% of the analyzed simulation. However,
1:POO mostly fluctuates between open (56%) and closed
(28%) conformations. We believe that the increased confor-
mational diversity observed in 1:POO is caused by the
disruption of hydrogen bonds between the D1 loop and
the thumb domain by POO as shown in Fig. 3. In addition
to the large-scale conformational changes, the local flexi-
bility of 1:POO is altered, which can be seen in the DRMSF
plots in Fig. 4. While residues within the fingers domain
involved in ligand binding become more rigid in 1:POO,
most other regions of the protein (residues: ~100, ~150,
~405, ~450, and ~515) become more flexible compared
to 1. The flexibility of these regions suggests that 1:POO
is intrinsically less stable than 1. Residues in the vicinity
of positions 100 and 400 in the enzyme participate in anti-
correlated motions for 1:POO (see Fig. S3), which are asso-
ciated with opening and closing of the fingers and thumb
domains. This motion is observed in the lowest frequency
mode derived from principal component analysis and is
provided as Movie S4 in the Supporting Material.FIGURE 4 DRMSF plots. Peaks above zero indicate residues that are
more flexible in the free enzyme, while peaks below zero indicate residues
that are more flexible in the ligand-bound enzyme. The bars at the bottom of
the plot indicate the locations of the fingers (F), palm (P), and thumb (T)
domains.
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1790 Davis et al.Overall, the motion of the thumb domain is disconnected
from the rest of the enzyme, because it no longer interacts
with the D1 loop. This suggests that the D1 loop is no
longer able to regulate transitions between open and closed
conformations, which is in contrast to what we observed in
our previous studies of the free enzyme (9) and to the sug-
gestions of Di Marco et al. (19) and Labonte´ et al. (44). The
divergent observations in these studies of 1:POO and previ-
ous investigations may result from the impact of POO
in destabilizing the enzyme and disrupting allosteric
communication pathways between the D1 loop and thumb
domain. This possibility could be tested by using amino-
acid substitutions to disrupt such interactions in the free
enzyme, to replicate the effects of having an NNI-1 ligand
present. For example, our simulations indicate that residues
S29, R32, and H33 in the D1 loop form hydrogen bonds
with the thumb domain (Fig. 3) and might be good choices
to mutate in order to mimic the behavior of an NNI-1
ligand. Similar mutations L30S and L30R were generated
by Labonte´ et al. (44). Both mutated enzymes were found
to be inactive and unable to incorporate nucleotides into
RNA transcripts.
The continuous sampling of several different conforma-
tions that we observe during our MD simulations is not
necessarily inconsistent with the predictions made by Di
Marco et al. (19) that the enzyme is locked in an open
conformation by NNI-1 inhibitors. These authors may
have observed only one of the two conformational minima
that we see in our studies. This enzyme could be trapped in
the more open state in their work due to crystal-packing
effects. In addition, as noted in Materials and Methods,
the PDB: 2BRL structure used for 1:POO contains a
loop with missing residues (22,29–34). The coordinates
of these residues were inserted by employing the corre-
sponding coordinates from the PDB: 2WHO structure.
It is possible that this flexible loop adopts a different
conformation in our simulations than actually present in
the PDB: 2BRL crystal structure. However, we believe
the loop conformation present in our simulations is accu-
rate because it was energy-minimized in the context of
the known coordinates before simulations for 1:POO
were initiated. In addition, these residues were subjected
to long periods of molecular dynamics to allow for equil-
ibration before any analysis was performed. The fact that
ligand binding at the NNI-1 site compromises the
enzyme’s ability to stably occupy the open and closed
conformations would likely prevent the enzyme from
stabilizing initiation or elongation complexes during
replication.Thumb site II (NNI-2) inhibitors reduce
conformational sampling
The NNI-2 binding site is located at the base of the thumb
domain (Fig. 1) and NNI-2 ligands are thought to inhibitBiophysical Journal 108(7) 1785–1795an initiation step of RNA synthesis (13,21,23). In a previous
study that examined 2 and 2:VGI, we found that the NNI-2
ligand VGI induces a hyperclosed conformation that we do
not believe to be replication-competent (28). The enzyme
appeared to be trapped in this state and thus prevented
from sampling other conformations. The hyperclosed
conformation was stabilized by hydrogen bonds between
the fingers and thumb domains that are also present in
closed conformations observed in this study (see discussion
below).
In this work, another crystal structure (PDB: 2HAI, sys-
tem 3 in Table 1) with a different inhibitor (PFI) in the
same thumb binding site as VGI (NNI-2) was simulated
to determine whether these structurally different ligands
(Fig. 2) induce the same hyperclosed conformation. In addi-
tion, PFI bound to the free structure generated previously
(2:PFI in Table 1) was simulated to control for the possible
impact of mutations in system 3 on its structure and dy-
namics. These mutations are all found in the fingers domain
and also occur in the NS5B from genotype 2a of HCV.
These are among several amino-acid changes that differen-
tiate genotype 2a from 1b, providing an opportunity to begin
to understand how different genotypes might respond to the
presence of inhibitors.
Our simulations suggest that PFI induces conformations
in both 2:PFI and 3:PFI that exhibit similar characteristics
(see Fig. S5). Thus, PFI induces similar conformations
regardless of enzyme sequence, suggesting that the ligand
is primarily responsible for the conformations observed
and not the three-point mutations in system 3 compared to
system 2. Hydrogen-bond analysis confirms that PFI has
the same interactions with the protein in both 2:PFI and
3:PFI, which is consistent with both PFI-bound enzymes
sampling conformational distributions that largely overlap
(see Fig. S5). A smaller template channel width is the
main characteristic that differentiates 2:PFI (75% open
conformation) and 3:PFI (96% open and intermediate
conformations) from system 3, which samples an open
conformation for 100% of the analyzed simulation. Both
PFI-bound structures sample conformations that are more
open compared to system 2 from our previous study (see
Fig. 2). System 2 mostly samples a closed conformation
(63%) and spends only 16% of the simulation in an open
conformation.
As previously mentioned, VGI induced a hyperclosed
conformation in 2:VGI not observed for 2:PFI or 3:PFI,
even though it binds to the same binding site (NNI-2).
The observation that PFI and VGI bind to the same NNI-2
site yet induce different conformational states is quite
remarkable and unanticipated. This suggests that the unique
local interactions between the ligand and protein are respon-
sible for different global effects. Hydrogen bonds involving
residues S476 and Y477 are thought to be important for the
potency of ligands in this binding site (13). Hydrogen-bond
analysis reveals that neither ligand forms a hydrogen bond
Allosteric Inhibitors of HCV Polymerase 1791with Y477 over the course of the simulations. However,
VGI forms a direct hydrogen bond with S476 while PFI
does not, instead forming a direct hydrogen bond with
R501. It is possible that this difference plays a role in inhib-
itor potency, because VGI has a lower IC50 value than PFI.
In either case, ligand binding disrupts the local hydrogen-
bonding network, which could propagate to induce the
global changes observed. The differences in inhibitor po-
tency for VGI and PFI may also relate to the degree to which
each ligand induces closed conformations. This is consistent
with the results of our simulations, with the more potent
VGI-producing conformations that are on average more
closed than those induced by PFI. Ligand potency could
also be related to the extent by which enzyme motions are
decreased due to the ligands, with VGI inducing more
dramatic reductions in NS5B motions than PFI (see Figs.
4 and S3).FIGURE 5 Hydrogen bonds that differentiate enzyme conformations. In
fully closed conformations the hydrogen bonds between R109 and D444
have occupancies of ~80% while the hydrogen bond between L91 and
C451 has an occupancy of ~20%. In the hyperclosed conformation, the
pattern is reversed: the hydrogen bonds between R109 and D444 have oc-
cupancies of ~20% and the hydrogen bond between L91 and C451 has an
occupancy ~80%. To see this figure in color, go online.Palm site I (NNI-3) Inhibitors limit conformational
sampling and block access of the RNA template
The NNI-3 binding site is at the intersection of the palm and
thumb domains adjacent to the active site (Fig. 1). The two
NNI-3 inhibitors examined in this study have similar scaf-
folds and engage in hydrophobic interactions and hydrogen
bonds with all three domains of NS5B. Similar types of in-
hibitors have been identified for other viral polymerases
(Dengue, herpes, and pestiviruses), suggesting that this
site provides an effective means of inhibiting polymerase
function in many viruses (45).
In contrast to systems 1 and 3, both systems 4 and 5
sample fully closed conformations for 100% of the
analyzed simulation (see Fig. 2). Hydrogen bonds between
the carbonyl oxygen of L91 and amino hydrogen of C451,
as well as between the guanidinium group of R109 and the
carbonyl oxygen of D444, are formed for both systems 4
and 5 and help stabilize the closed state (see Fig. 5). These
hydrogen bonds are also observed in the hyperclosed
conformation, but with opposite patterns of occupancy
(28). Although they still sample closed conformations,
the ligand-bound systems 4:3MS and 5:77Z sample confor-
mations that are more open than those sampled by systems
4 and 5 (see Fig. 2). The ligand-bound structures also
display different patterns of hydrogen bonds. Neither
palm-bound system exhibits the hydrogen bond between
L91 and C451 and only 4:3MS achieves the hydrogen
bonds between R109 and D444 observed for systems 4
and 5. In addition, the two inhibitors form hydrogen bonds
that are unique to each system: 3MS with N291 and 77Z
with Y448. These differences in hydrogen bonding could
be due to the slight variation in ligand structure between
3MS and 77Z (see Fig. 1). Despite these differences,
both ligands appear to induce similar structural and dy-
namic changes in NS5B. As shown in Fig. 2, both 3MS
and 77Z lock the enzyme into partially closed conforma-tions and prevent the enzyme from sampling other confor-
mational states.
Palm inhibitors have been suggested to prevent the initi-
ation of replication by physically blocking access of tem-
plate RNA and incoming NTPs to the active site (13).
Results from our simulations are consistent with this obser-
vation. Structural alignments of average structures taken
from our simulations of 4:3MS or 5:77Z with a template-
enzyme complex (PDB: 1NB7) indicate that palm inhibitors
stably occupy locations that would hinder the template from
accessing the catalytic site. This effect should significantly
diminish enzyme activity (see Fig. 6 for 4:3MS).The free enzyme can assume open conformations
suitable for elongation
Free enzymes that were generated from crystal structures
containing inhibitors bound to the thumb domain (systems
1–3) predominantly sampled conformations that were
more open than their corresponding ligand-bound struc-
tures. However, both systems 1 and 3 sample conformations
that are even more open than system 2. Fig. S6 shows pro-
totypical structures that represent the spectrum of conforma-
tions sampled by the different simulations, including the
open conformation sampled by system 3. The RMSD values
between these structures are provided in Table S7 in the
Supporting Material.
While the fully closed conformation may favor initiation,
the open conformation observed for systems 1 and 3 may beBiophysical Journal 108(7) 1785–1795
FIGURE 6 NNI-3 ligands obstruct the RNA template. Structural align-
ment between the average structure from 4:3MS and x-ray structure
PDB: 1NB7 containing a short template strand. It is apparent that the
path of the template to the active site would be blocked by the presence
of the ligand. To see this figure in color, go online.
1792 Davis et al.suitable for elongation. Although the presence of this state
has been inferred based on the structural requirements for
replication, to our knowledge, it has not previously been
observed in molecular detail. It is possible that the 400-ns
simulations performed for system 2 in our earlier studies
were too short compared to the much longer simulations
for systems 1 and 3 (at least 700 ns; see Table 1) for this state
to be observed in that work (28). In the open conformation
observed for systems 1 and 3, the fingers and thumb do-
mains have rotated away from each other as shown in the
average structures (Fig. S6). The average q and duplex chan-
nel widths for systems 1 and 3 are (76.1, 21.1 A˚) and
(75.7, 22.2 A˚), respectively. In contrast, a crystal structure
of NS5B from genotype 2, previously classified as open
(PDB: 1YV2), has an angle of 71.5 and a duplex channel
width of 17.3 A˚ (39). Similarly, a structure of the related
RNA polymerase from Poliovirus (PDB: 3OL6) that con-
tains double-stranded RNA displays a duplex channel width
of 18.6 A˚ (37). Because they contain duplex channels that
are even wider than those observed for PDB: 1YV2 and
PDB: 3OL6, the open conformations observed for systems
1 and 3 should be able to readily accommodate double-
stranded RNA and should be well suited for elongation of
the RNA strand.Inhibitor binding can disrupt long-range
communication within NS5B
We generated network graphs to represent the communica-
tion pathways in the enzyme using the NETWORKVIEW
plugin for VMD (41) (see Materials and Methods). This
analysis was performed to understand how long-range
communication between residues in the enzyme changes
upon ligand binding. While differences exist, there are
several regions with similar collections of critical residuesBiophysical Journal 108(7) 1785–1795among the different systems. In particular, there are changes
to community organization upon ligand binding. Fig. S8
shows the differences in community composition between
1 and 1:POO. The changes are representative of the manner
in which ligand binding affects community composition.
The ligand is able to induce effects distal to its binding
site, as illustrated by the fact that communities in the fingers
domain also change upon POO binding (see Fig. S8).
The large number of critical residues in each system sug-
gests that allosteric communication can occur along many
different pathways. If such communication is functionally
significant, this occurrence may have implications in allow-
ing the enzyme to become resistant to allosteric inhibitors.
While binding of allosteric inhibitors may abolish some of
these communication pathways, there may be other routes
within the enzyme that can also fulfill these roles.
Table S9 lists the number of communities and critical res-
idues identified for each system and the location of these
residues within different structural motifs of NS5B. In
most cases, NS5B has a larger number of critical residues
when it is bound to thumb inhibitors than when it is free
of ligand. The increase in critical residues is due to an
increased number of communities, which indicates that
the enzyme dynamics as a whole is less cohesive. Thus, in
general, there is a lower level of globally coupled dynamics
in the presence of thumb inhibitors. The only exception to
this is 2:PFI. In general, PFI does not alter the dynamics
of the enzyme as much as the other inhibitors.
In contrast, the palm inhibitors induce varying effects
when compared to their free enzyme counterparts. While
3MS reduces the number of communities and critical resi-
dues, 77Z increases the number of communities and critical
residues. Thus, the influence on enzyme dynamics appears
to differ based on specific interactions formed between the
enzyme and these ligands.Critical residues highlight functional roles of
structural motifs
Fig. S10 shows the locations of the different motifs and
functional regions on the enzyme structure. All systems
have critical residues in motif F as well as functional region
II. Both motifs are important for template binding. Most
systems have critical residues in motif B and functional re-
gions III. Motifs B and F also play a role in NTP binding,
while functional region III is required to bind the nascent
RNA strand. The observation that all or most systems
have critical residues in these regions suggests that these
residues occur along allosteric pathways that mediate allo-
steric effects in both free and ligand-bound states.
While critical residues that are common to multiple
enzyme systems may be of fundamental importance to
numerous functional properties, critical residues that occur
only in distinct conformations may be important for specific
functional roles performed in that state. As a case in point,
Allosteric Inhibitors of HCV Polymerase 1793all free enzymes that sampled closed conformations had
critical residues in functional region I or motif G. Both re-
gions are located at the top of the fingers domain lining
the template channel and are responsible for RNA template
binding.
These results allow us to hypothesize why residues in spe-
cific regions may be critical. Critical residues in regions
involved in template binding (i.e., motifs B, F, and G and
functional regions I and II) may signal to other enzyme re-
gions that template recognition has occurred in the closed
conformation. In contrast, critical residues in regions
involved in binding of the nascent RNA strand (motif E
and functional region III) may signal the transition to the
open conformation to allow the double-stranded RNA to
exit the enzyme. There was not a trend observed for motifs
A, C, D, and E, which play roles in catalysis. This may be
because the simulations did not contain template RNA
bound to the enzyme, and thus would not be expected to
sample conformations or engage in patterns of dynamics
directly relevant to the catalytic event.CONCLUSIONS
Our observations provide insight into the mechanisms of in-
hibition mediated by three distinct allosteric binding sites of
the HCV RNA polymerase NS5B. We find that ligands at
each of the three sites induce distinct patterns of conforma-
tional sampling and enzyme flexibility. The NNI-1 inhibitor
destabilizes the enzyme by disrupting key interactions be-
tween the fingers and thumb domains, preventing conforma-
tions necessary for function from being stably occupied. In
contrast, NNI-2 inhibitors reduce conformational sampling
of the enzyme, locking it into either a more closed or a
more open conformation, depending on the specific inhibi-
tor in question. The NNI-3 inhibitors are similar to NNI-2
inhibitors in that they also restrict the conformational sam-
pling of the enzyme, although both of the inhibitors studied
in this work lock the enzyme into more open conformations
relative to the free enzyme. In addition, NNI-3 inhibitors
may prevent the RNA template from accessing the active
site. Given that the binding site for NNI-4 inhibitors
partially overlaps that of NNI-3 inhibitors, it is likely that
the observations made for NNI-3 inhibitors will also apply
to NNI-4. In summary, we have observed that allosteric
inhibitors likely prevent polymerase function through
three mechanisms: 1) eliminating transitions between the
two major functional conformations (the closed conforma-
tion required for initiation and the open conformation
required for elongation), 2) destabilizing the enzyme and
preventing it from stably sampling functional conforma-
tions, and 3) preventing the RNA template from accessing
the active site.
In addition to illuminating the molecular mechanisms
by which allosteric inhibitors may alter functional proper-
ties of the HCV polymerase, our findings inform us aboutthe fundamental functional properties of the enzyme. Spe-
cifically, we observe that conformations likely to be suitable
for the initiation and elongation of RNA replication can
occur in the free enzyme. Systems 4 and 5 sampled closed
conformations suitable for the initiation of replication
while systems 1 and 3 sampled open conformations that
may readily accommodate double-stranded RNA present
during elongation.
The graph theoretic analysis afforded by the
NETWORKVIEW plugin for VMD (41) provides insight
into how allosteric inhibitors alter long-range communica-
tion networks in NS5B. With this knowledge it should be
possible to alter the function of the enzyme in well-defined
ways via amino-acid substitution targeted to critical residues.
For example, it should be possible to generate enzymes with
native dynamics even in the presence of inhibitor (i.e., a resis-
tant enzyme). It should also be possible to generate enzymes
with perturbed dynamics in the absence of an inhibitor. We
are in the process of performing such studies.
Many viral polymerases such as HIV-RTand 3D-pol from
poliovirus share similar structural and dynamic elements
with NS5B. Thus, the knowledge gained in this study may
be relevant to understanding the intrinsic functional proper-
ties of a large number of viral polymerases, as well as how
to alter the function of these and other enzymes via small
molecules.SUPPORTING MATERIAL
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